ScholarIQanswers from OpenAlex & ORCID
Karl Kieburtz
ResearcherPublications, citations & collaboration network
Karl Kieburtz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Karl Kieburtz have?
ScholarIQindexed works
Karl Kieburtz has 247 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Karl Kieburtz have?
ScholarIQcitation count
Karl Kieburtz has 21,299 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Karl Kieburtz?
ScholarIQh-index
Karl Kieburtz has an h-index of 69 in OpenAlex.
What is the i10-index of Karl Kieburtz?
ScholarIQi10-index
Karl Kieburtz has an i10-index of 157 in OpenAlex.
What is the ORCID of Karl Kieburtz?
ScholarIQorcid
The ORCID for Karl Kieburtz is on the source record.
What is the OpenAlex record for Karl Kieburtz?
ScholarIQopenalex
The OpenAlex for Karl Kieburtz is on the source record.
What are the most-cited papers on Karl Kieburtz?
ScholarIQmost cited works
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
E. Ray Dorsey, Radu Constantinescu, James P. Thompson, Kevin Biglan, Robert G. Holloway, Karl Kieburtz, Fred Marshall, Bernard Ravina, Giovanni Schifitto, Andrew Siderowf, Caroline M. Tanner
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul Aisen, Eric Siemers, Hong Liu‐Seifert, Richard C. Mohs
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
C. Warren Olanow, Karl Kieburtz, Per Odin, Alberto J. Espay, David G. Standaert, Hubert H. Fernandez, Arvydas Vanagunas, Ahmed A. Othman, Katherine L. Widnell, Weining Robieson, Yili Pritchett, Krai Chatamra, Janet Benesh, Robert Lenz, Angelo Antonini
The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
Kenneth Marek, Sohini Chowdhury, Andrew Siderowf, Shirley Lasch, Christopher S. Coffey, Chelsea Caspell‐Garcia, Tanya Simuni, Danna Jennings, Caroline M. Tanner, John Q. Trojanowski, Leslie M. Shaw, John Seibyl, Norbert Schuff, Andrew Singleton, Karl Kieburtz, Arthur W. Toga, Brit Mollenhauer, Doug Galasko, Lana M. Chahine, Daniel Weintraub, Tatiana Foroud, Duygu Tosun, Kathleen L. Poston, Vanessa Arnedo, Mark Frasier, Todd Sherer, the Parkinson's Progression Markers Initiative
HIV-associated cognitive impairment before and after the advent of combination therapy
Ned Sacktor, Michael McDermott, Karen Marder, Giovanni Schifitto, Ola A. Selnes, Justin C. McArthur, Yaakov Stern, Steven M. Albert, Donna Palumbo, Karl Kieburtz, Joy Antonelle de Marcaida, Bruce A. Cohen, Leon G. Epstein